Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.
Satellos Bioscience is a private regenerative medicine company developing novel therapeutics that stimulate or restore muscle regeneration.
Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.
Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.
Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
Forte Biosciences is a biotechnology company that focuses on dermatology.
Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.
Merida Biosciences is a biotech company focused on developing precision treatments, particularly for autoimmune diseases.
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.
VitalConnect offers wearable biosensor technology for wireless patient monitoring in both hospital and remote patient populations.
Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.
Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.
Axonis Therapeutics is a neuro-focused biotechnology company that focuses on the development of novel neuromedicines.
Genome Medical is a telegenomics technology and services company allowing access to genomic-based medicine.
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Earli develops genetic constructs for early cancer detection and targeted therapy.
ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.
Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.
IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.
Perceptive Advisors has invested in 224 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Perceptive Advisors's top investment sectors include Biotechnology, Health Care, Life Science, Medical, Pharmaceutical. The firm invests across 17 different industry categories.
Among tracked funding rounds, Avidity Biosciences received $690.0M in a Post Ipo Equity round. Perceptive Advisors's total known invested capital is $26.6B.
Perceptive Advisors's average investment size is $135.1M across its portfolio of 224 companies.
Recent Perceptive Advisors portfolio additions include DarioHealth, Satellos Bioscience, Oruka Therapeutics, Avidity Biosciences, Amylyx Pharmaceuticals. These companies were founded in 2020 or later.